CVS HEALTH Corp (CVS) Overview
Consumer Discretionary • NYSE • CIK 0000064803
Loading...
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Market Cap
$114.94B
P/E (TTM)
10.4x
Rev Growth (TTM)
+6.7%
Net Margin (TTM)
2.6%
FCF Yield (TTM)
13.5%
FCF Margin (TTM)
3.7%
Figures as of September 30, 2026
Filings
Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.
10-Q2026 Q32026-11-04source
8-KNov 20262026-11-04source
8-KEarnings2026-11-04source
8-KAug 20262026-08-17source
10-Q2026 Q22026-08-05source
What your agent reads
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q3
12 days ago
8-K releaseRevenue
$108.40B
—
Net Income
$2.17B
—
EPS
$1.68
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$15.6B
Q3 '26
$3.9B-31%
Q2 '26
$5.7B+66%
FCF Margin
TTM3.7%
Q3 '263.6%-32%
Sector: 3.2%Above Avg
OCF Margin
4.4%
OCF/NI1.70x
CapEx Coverage
6.0x
FCF Yield13.5%
FCF Growth (3Y)+11%
Cash Conversion Cycle
–
DSO: 36+DIO: 28−DPO: –
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder Yield
TTM3.0%
Div Yield3.0%
Dividend & Payout Metrics
Dividend Yield (TTM)3.0%
FCF Payout Ratio21.9%
Free Cash Flow (TTM)$15.6B
Stock Repurchases ()$0
Capital Return / FCF22.0%
Shares Outstanding (YoY)0.8%
Est. Dividends Paid (TTM)$3.4B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
10.4x
Volatile
8Q: 9.8x-23%
Valuation Lenses
Earnings
10.4x
vs – sector
Cash Flow
10.3x
EV/FCF vs –
Growth-Adj
0.0xPEG
Undervalued for growth
Quality-Adj
1.1P/E per %ROIC
ROIC: 9.8%
Shareholder Returns
Dividend
3.0%
Buyback
–
Total Yield
3.0%
Market Cap$114.94B
EV$160.74B
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 59th pctile
Profitability Cascade
Gross
44.2%
Operating
3.6%
Below Avg in sector
Net
2.6%
Margins Unknown
Return on Invested CapitalTTM
9.8%
Moderate
+0.1% YoY8Q: 7.0%+6.0%
P25MedianP75
59th pctl (med: 6.8%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
3.3%
8Q: 2.5%
Asset Turnover
1.65x
8Q: 1.59x
Leverage (1+D/E)
1.75x
D/E: 0.75x
DuPont: 9.5% ≈ 9.8% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
32.13x
8Q:31.44x
+269.9%
Invested Cap Turn
3.35x
8Q:3.23x
+52.5%
CapEx Intensity
2.5%
8Q:2.3%
CapEx/Depreciation
0.69x
FCF vs Net Margin Gap+1.1 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
ND/EBITDA 2.7x
Net Debt / EBITDA
2.7xNet Debt: $45.79B
Interest Coverage
4.9x
Leverage Metrics
Debt-to-Equity
0.75x
Balance sheet risk & solvency analysis
Related Research
2 related posts